# Takeda Pharmaceutical Co Ltd: Form 6-K, filed Jul 1, 2025

- Company: [Takeda Pharmaceutical Co Ltd](/companies/tak.md) (CIK 1395064)
- Form: 6-K
- Filed: 2025-07-01
- Accepted by EDGAR: Jul 1, 2025, 06:03 ET
- Period: 2025-07-01
- Accession: 0001395064-25-000107
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1395064/000139506425000107/form6k_070125.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395064/000139506425000107/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395064/000139506425000107/form6k_070125.htm

Filed Jul 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001395064-25-000107. Last ingested by Listed: Nov 5, 2026, 16:17 ET. No prices; not investment advice.